Pfizer (NYSE:PFE)

Prescription drugs

Major Pharma Short Interest Faces Significant Drop

The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer Inc. (NYSE: PFE) has finally reeled in cancer-drug maker Medivation Inc. (NASDAQ: MDVN) for a whopping $81.50 a ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
thinkstockphotos-522646895

3M, Chevron Pull Dow Higher Wednesday

August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector while consumer discretionary stocks weighed most heavily. WTI crude oil ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
buy sell stocks

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

With interest rates at embarrassingly low levels and with stocks at all-time highs, many investors have turned to key dividend-paying stocks to generate income and hopefully to achieve long-term upside. ...
Read Full Story »
NYSE

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that the rising tide did not actually lift all ships. There ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Slides

The short interest data have been released for the July 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
dividends

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out. Investors and traders alike need to know that the short sellers are now fighting the market at all-time highs. ...
Read Full Story »
thinkstockphotos-522646895

Healthcare Stocks Sink DJIA on Monday

August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength ...
Read Full Story »
white pills

Why Allergan Earnings Aren’t Telling the Whole Story

The big news for Allergan PLC (NYSE: AGN) came early in the second quarter, when Pfizer Inc. (NYSE: PFE) terminated its proposed $160 billion acquisition of the Ireland-based maker of Botox. ...
Read Full Story »
market crash

Apple, Pfizer Sink DJIA on Tuesday

August 2, 2016: Markets opened nearly flat again Tuesday on stronger oil prices early in the day before reality set in. As it is, energy is the sole sector that ...
Read Full Story »
Pfizer

Pfizer Earnings Fail to Impress Investors

Pfizer Inc. (NYSE: PFE) reported its second-quarter financial results before the markets opened on Tuesday. In the most recent quarter, the company was competitively positioning itself in terms of its pipeline and ...
Read Full Story »
coins

What to Expect From Pfizer Earnings

When talking about the pharmaceutical industry, Pfizer Inc. (NYSE: PFE) is bound to come up, even more so with its second-quarter earnings just around the corner. This mega-pharma has been ...
Read Full Story »
ThinkstockPhotos-475180302

The Top 10 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of the top 10 major companies reporting their quarterly results this week. We are in the heart of earnings season in which most major ...
Read Full Story »